Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?

Translational Research

Volumn 151, Issue 5, 2008, Pages 240-245

  SubirÁ, Dolores ^a   Font, Patricia ^a   Villalón, Lucia ^a   Serrano, Cristina ^a   Askari, Elham ^a   Góngora, Elena ^a   Castañón, Susana ^a   Gonzalo, Raquel ^a   Mata, Raquel ^a   Román, Alejandro ^a   Llamas, Pilar ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CELLULAR DISTRIBUTION; CHRONIC MYELOMONOCYTIC LEUKEMIA; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 46349096377     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2008.03.001     Document Type: Article

References (13)

1. Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of myelodysplastic syndromes. Br J Haematol 51 (1982) 189-199
2. Vardiman J.M., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
3. Onida F., Kantarjian H.M., Smith T.L., et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood 99 (2002) 840-849
4. Bennett J.M., Catovsky D., Daniel M.T., et al. The chronic myeloid leukaemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 87 (1994) 746-754
5. Germing U., Gattermann N., Minning H., Heyll A., and Aul C. Problems in the classification of CMML-dysplastic versus proliferative type. Leuk Res 22 (1998) 871-878
6. Stetler-Stevenson M., Arthur D.C., Jabbour N., et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 98 (2001) 979-987
7. Wells D.A., Benesch M., Loken M.R., et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after haematopoietic stem cell transplantation. Blood 102 (2003) 394-403
8. Loken M.R., van de Loosdrecht A., Ogata K., Orfao A., and Wells D.A. Flow cytometry in myelodysplastic syndromes: Report from a working conference. Leuk Res 32 (2008) 5-17
9. Lacronique-Gazaille C., Chaury M.P., Le Guyader A., Faucher J.L., Bordessoule D., and Feuillard J. A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML. Haematologica 92 (2007) 859-860
10. Xu Y., McKenna R.W., Karandikar N.J., Pildain A.J., and Kroft S.H. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol 124 (2005) 799-806
11. Beran M., Shen Y., Onida F., Wen S., Kantarjian H., and Estey E. Prognostic significance of monocytosis in patients with myeloproliferative disorders. Leuk Lymphoma 47 (2006) 417-423
12. Sternberg A., Killick S., Littlewood T., et al. Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome. Blood 106 (2005) 2982-2991
13. Germing U., Strupp C., Knipp S., et al. Chronic myelomonocytic leukemia in the light of the WHO proposals. Haematologica 92 (2007) 974-977